The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Koya, Richard
One or more keywords matched the following items that are connected to Koya, Richard
Item TypeName
Concept Proto-Oncogene Proteins B-raf
Academic Article A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.
Academic Article Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Academic Article The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
Academic Article Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Academic Article Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.
Academic Article BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
Academic Article Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
Academic Article Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.
Academic Article Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors.
Academic Article RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
Academic Article Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Academic Article Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
Academic Article Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction.
Academic Article Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
Search Criteria
  • Oncogene Proteins v raf